Mykronor Noradrenaline 5 μg/mL Medication Error DHPC

HPRA Ireland distributed a safety communication from Laboratoire Aguettant concerning Mykronor (Noradrenaline) 5 μg/mL solution for injection/infusion. The DHPC identifies a potential risk of medication errors associated with this specific noradrenaline formulation and provides safety information to direct healthcare professionals.

Healthcare providers including hospitals, pharmacies, and clinical staff who handle this product should review the full DHPC document to understand the specific nature of the medication error risk and any recommended mitigations. Pharmaceutical procurement and clinical quality teams should assess whether current handling or prescribing practices for this product are affected by the identified risks.